Fundz

Psyence Biomedical Ltd reported raising $2 Million in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEJan 07, 2025

Amount Raised

$2 Million

$2 Million sold, per SEC Form D (first sale Dec 27, 2024)

Round Type

Seed

TorontoBiotechnologyHealth Care

Quick answer

Psyence Group raised $2 Million in a Seed round, dated December 27, 2024. Psyence Group is based in Toronto, Ontario, Canada.

How much did Psyence Group raise?
Psyence Group raised $2 Million in a Seed round on December 27, 2024.
What does Psyence Group do?
www.psyence.com Psyence is a life science biotechnology company listed on the Canadian Securities Exchange (CSE: PSYG), with a focus on natural psychedelics.
Where is Psyence Group based and how big is it?
Psyence Group is based in Toronto, Ontario, Canada. Fundz records about 10 employees.
Who are the decision-makers at Psyence Group?
Fundz holds 2 contacts at Psyence Group. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Psyence Group that raised within 45 days of this round, from Fundz verified event records.

  • Acasti raised $15M on February 10, 2025.
  • Pneuma Respiratory raised $3.3M (Seed) on February 10, 2025.
  • neurocare raised $20M (Funding Round) on February 10, 2025.
  • Insight Molecular Diagnostics Inc. raised $22M on February 10, 2025.
  • Solstice Health raised $3.5M (Seed) on February 10, 2025.
  • Abcuro raised $80M on February 7, 2025.

Who to call at Psyence Group, and when

A new round usually means Psyence Group is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Psyence Group raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Psyence Group, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Psyence Group. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Psyence Group

Location

Toronto, Ontario, Canada

About

www.psyence.com Psyence is a life science biotechnology company listed on the Canadian Securities Exchange (CSE: PSYG), with a focus on natural psychedelics. Psyence works with nature-derived psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. Our name “Psyence” combines the words psychedelic and science to affirm our commitment to producing psychedelic medicines developed through evidence-based research. Informed by nature and guided by science, we built and operate one of the world’s first federally licensed commercial psilocybin mushroom cultivation and production facilities in Southern Africa. Our team brings international experience in both business and science and includes experts in mycology, neurology, palliative care, and drug development. We work to develop advanced nature-derived psilocybin products for clinical research and development. Our key divisions, Psyence Production and Psyence Therapeutics anchor an international collaboration, with operations in Canada, the United Kingdom, Southern Africa and Australia, and a presence in the United States.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Psyence Group raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Psyence Group's next move

See what Strategic adds

Psyence Group raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.